Neuropharmacology· 2020Q1
Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
- 1,089citations
- Q1SCImago
- 2020year
Short summary
Current acetylcholinesterase inhibitors (ChE-Is) for Alzheimer's disease (AD) offer mild, potentially not clinically significant benefits, with similar efficacy across available drugs like donepezil, rivastigmine, and galantamine.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Pharmacology
PharmacologyMedicine